Ferric Derisomaltose Compared to Iron Sucrose in Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Basit Öğe Kaydı
dc.contributor.authorTanriverdi, Lokman H.
dc.contributor.authorSarici, Ahmet
dc.contributor.authorAksan, Feyzullah
dc.contributor.authorHernandez, Adrian V.
dc.date.accessioned2026-04-04T13:31:01Z
dc.date.available2026-04-04T13:31:01Z
dc.date.issued2026
dc.departmentİnönü Üniversitesi
dc.description.abstractBackground/Objectives: There are conflicting results on the effects of ferric derisomaltose (FDM) vs. iron sucrose (IS) for treatment of iron deficiency anemia (IDA). We systematically assessed the efficacy and safety of these treatments. Methods: We searched Ovid MEDLINE, Web of Science, Pubmed, and Cochrane Central for randomized controlled trials (RCTs) comparing the efficacy and/or safety of FDM vs. IS in patients with IDA. The primary efficacy outcome was the change in hemoglobin (Hb) levels at week 4, and the safety outcome was serious or severe hypersensitivity reactions, as defined by a standardized set of Medical Dictionary for Regulatory Activities (MedDRA) terms. Inverse-variance random effects models were used for meta-analyses. Results: Five RCTs were included: two in general IDA (n = 1994), two in non-dialysis chronic kidney disease (n = 1542), and one in hemodialysis patients (n = 344). The evidence was very uncertain about the effect of FDM vs. IS for Hb change at week 4 (mean difference [MD] 0.09 g/dL, 95% CI -0.33 to 0.52; I2 = 84%, very low CoE), serious or severe hypersensitivity reactions (MedDRA A + B + C + D, relative risk [RR] 0.83, 95% CI 0.25 to 2.68; I2 = 0%, very low CoE), Hb change at week 8 (MD 0.04 g/dL, 95% CI -0.08 to 0.15; I2 = 0%, very low CoE), Hb increase of >= 2 g/dL at week 4 (RR 1.16, 95% CI 0.97 to 1.38; I2 = 70%, very low CoE), and anaphylactic reactions (MedDRA A, RR 0.38, 95% CI 0.08 to 1.72; I2 = 0%, very low CoE). Conclusions: We found that FDM vs. IS had little to no effect on outcomes for the treatment of IDA.
dc.description.sponsorshipIdot;nn University Scientific Research Projects Unit [TSA-2026-4656]
dc.description.sponsorshipThis research was supported by a research grant from & Idot;nonu University Scientific Research Projects Unit (Project no: TSA-2026-4656).
dc.identifier.doi10.3390/jcm15051919
dc.identifier.issn2077-0383
dc.identifier.issue5
dc.identifier.pmid41827336
dc.identifier.scopus2-s2.0-105032812566
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.3390/jcm15051919
dc.identifier.urihttps://hdl.handle.net/11616/108537
dc.identifier.volume15
dc.identifier.wosWOS:001713651700001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherMdpi
dc.relation.ispartofJournal of Clinical Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250329
dc.subjectferric derisomaltose
dc.subjectiron sucrose
dc.subjectiron deficiency anemia
dc.subjectanaphylaxis
dc.subjectmeta-analysis
dc.titleFerric Derisomaltose Compared to Iron Sucrose in Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu